• Explore /
  • Poster
  • / A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (LASER).

A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (LASER).

Abstract Poster

Authors

null

Nicholas I. Simon

Genitourinary Malignancies Branch, CCR, NCI, NIH, Bethesda, MD

Nicholas I. Simon , Elias Chandran , Scot Anthony Niglio , Andre Rashad Kydd , Saad Omar Atiq , Lisa Ley , Tzu-fang Wang , Salah Boudjadi , Elizabeth Smith , Dilara Akbulut , Seth M. Steinberg , Andrea B Apolo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Other GU Kidney and Bladder Cancer

Clinical Trial Registration Number

NCT06228066

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS4629)

DOI

10.1200/JCO.2024.42.16_suppl.TPS4629

Abstract #

TPS4629

Poster Bd #

313a

Abstract Disclosures

Similar Posters

First Author: Patrick Walsh McGarrah

First Author: Jorge Hernando

First Author: Evangelia Vlachou

First Author: Xiaoting Ma